TGFB1 and systemic sclerosis: These observations may elucidate the effect of ATRA in reducing DNA methylation, especially at the proximal promoter in the FOXP3 locus, which plays an important pharmacological role in the treatment of SSc, and this function is not affected by TGF-β.